[1]郑泽兵,刘远梅,张帆,等.降钙素原、白细胞介素6、C反应蛋白在新生儿坏死性小肠结肠炎手术时机选择中的应用价值研究[J].临床小儿外科杂志,2019,18(05):361-367.[doi:10.3969/j.issn.1671-6353.2019.05.005]
 Zheng Zebing,Liu Yuanmei,Zhang Fan,et al.Applicable value of operative opportunity for procalcitonin, interleukin-6 and C-reactive protein in neonatal necrotizing enterocolitis[J].Journal of Clinical Pediatric Surgery,2019,18(05):361-367.[doi:10.3969/j.issn.1671-6353.2019.05.005]
点击复制

降钙素原、白细胞介素6、C反应蛋白在新生儿坏死性小肠结肠炎手术时机选择中的应用价值研究

参考文献/References:

1 Lin PW,Stoll BJ.Necrotising enterocolitis[J].Lancet,2006,368(9543):1271-1283.DOI:10.1016/S0140-6736(06)69525-1.
2 Coombs RC.The prevention and management of necrotizing enterocolitis[J].Curr Paediatr,2003,13(3):184-189.DOI:org/10.1016/S0957-5839(03)00025-3.
3 史婧奕,吕志宝.双歧杆菌三联活菌散预防早产儿坏死性小肠结肠炎的临床初探[J].临床小儿外科杂志,2016,15(1):72-75.DOI:10.3969/j.issn.1671-6353.2016.01.021.Shi JY,Lv ZB.The clinical study of preventing necrotizing enterocolitis in premature infants by bifido triple viable powder supplementation[J].J Clin Ped Sur,2016,15(1):72-75.DOI:10.3969/j.issn.1671-6353.2016.01.021.
4 Bradshaw WT.Necrotizing enterocolitis:etiology,presentation,management,and outcomes[J].J Perinat Neonatal Nurs,2009,23(1):87-94.DOI:10.1097/JPN.0b013e318196fefb.
5 陈明祥,金先庆.新生儿坏死性小肠结肠炎手术治疗进展[J].临床小儿外科杂志,2012,11(4):298-301.DOI:10.3969/j.issn.1671-6353.2012.04.020.Chen MX, Jin XQ.Advances in surgeries for neonatal necrotizing enterocolitis[J].J Clin Ped Sur,2012,11(4):298-301.DOI:10.3969/j.issn.1671-6353.2012.04.020.
6 Cetinkaya M,Ozkan H,Köksal N,et al.Comparison of the efficacy of serum amyloid A,C-reactive protein,and procalcitonin in the diagnosis and follow-up of necrotizing enterocolitis in premature infants[J].J Pediatr surg,2011,46(8):1482-1489.DOI:10.1016/j.jpedsurg.2011.03.069.
7 Turner D,Hammerman C,Rudensky B,et al.Low levels of procalcitonin during episodes of necrotizing enterocolitis[J].Dig Dis Sci,2007,52(11):2972-2976.DOI:10.1007/s10620-007-9763-y.
8 Lodha A,Howlett A,Ahmed T,et al.The Role of Interleukin-6 and Interleukin-8 Circulating Cytokines in Differentiating between Feeding Intolerance and Necrotizing Enterocolitis in Preterm Infants[J].Am J Perinatol,2017,34(13):1286-1292.DOI:10.1055/s-0037-1603329.
9 许笑南,何少茹,郑曼利,等.新生儿坏死性小肠结肠炎各期危险因素差异分析[J].中华实用儿科临床杂志,2013,28(19):1483-1486.DOI:10.3969/cma.j.issn.2095-428X.2013.19.013.Xu XN,He SR,Zheng ML,et al.Analysis of the difference of risk factors between each stage of necrotizing enterocolitis[J].Chin J Appl Clin Pediatr,2013,28(19):1483-1486.DOI:10.3969/cma.j.issn.2095-428X.2013.19.013.
10 牟廷刚,金先庆.早产儿肠道因素对新生儿坏死性小肠结肠炎发病机制的影响[J].临床小儿外科杂志,2011,10(2):142-144.DOI:10.3969/j.issn.1671-6353.2011.02.024.Geng TG,Jin XQ.Effect of intestinal factors in premature infants on the pathogenesis of neonatal necrotizing enterocolitis[J].J Clin Ped Sur,2011,10(2):142-144.DOI:10.3969/j.issn.1671-6353.2011.02.024.
11 Terrin G,Stronati L,Cucchiara S,et al.Serum Markers of Necrotizing Enterocolitis:A Systematic Review[J].J Pediatr Gastroenterol Nutr,2017,65(6):120-132.DOI:10.1097/MPG.0000000000001588.
12 Zhang H,Chen J,Wang Y,et al.Predictive factors and clinical practice profile for strictures post-necrotising enterocolitis[J].Medicine,2017,96(10):6273-6281.DOI:10.1097/MD.0000000000006273.
13 Reisinger KW,Kramer BW,Van der Zee DC,et al.Non-invasive serum amyloid A (SAA) measurement and plasma platelets for accurate prediction of surgical intervention in severe necrotizing enterocolitis (NEC)[J].PLoS One,2014,9(6):90834-90840.DOI:10.1371/journal.pone.0090834.
14 Liu Y,Qingjuan S,Gao Z,et al.Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis[J].Medicine,2017,96(26):7400-7408.DOI:10.1097/MD.0000000000007400.
15 Köksal N,Harmanci R,Cetinkaya M,et al.Role of procalcitonin and CRP in diagnosis and follow-up of neonatal sepsis[J].Turk J Pediatr,2007,49(1):21-29.
16 Benkoe T,Baumann S,Weninger M,et al.Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizingenterocolitis[J].PLoS One,2013,8(3):e58720.DOI:10.1371/journal.pone.0058720.
17 Hackam DJ,Afrazi A,Good M,et al.Innate immune signaling in the pathogenesis of necrotizing enterocolitis[J].Clin Dev Immunol,2013,54(32):215-225.DOI:10.1155/2013/475415.
18 Isaacs D,North J,Lindsell D,et al.Serum acute phase reactants innecrotizing enterocolitis[J].Acta Paediatr Scand,1987,76(6):923-927.
19 Zangari A,Noviello C,Nobile S,et al.Surgical management of Necrotizing Enterocolitis in an Incredibly Low Birth Weight infant and review of the Literature[J].Clin Ter,2017,168(5):297-299.DOI:10.7417/T.2017.2024.
20 Pourcyrous M,Korones SB,Yang W,et al.C-reactive protein in the diagnosis,management and prognosis of neonatal necrotizing enterocolitis[J].Pediatrics,2005,116(5):1064-1069.DOI:10.1542/peds.2004-1806.

相似文献/References:

[1]侯龙龙 李仲荣 黄璜. 新生儿坏死性小肠结肠炎预后相关因素分析[J].临床小儿外科杂志,2014,13(05):396.
[2]史婧奕,吕志宝.. 双歧杆菌三联活菌散预防早产儿坏死性小肠结肠炎的临床初探[J].临床小儿外科杂志,2016,15(01):72.
[3]潘登,王献良,邵雷朋..新生儿坏死性小肠结肠炎经回肠造瘘术后远端肠闭锁7例[J].临床小儿外科杂志,2016,15(05):513.
[4]臧婧羽,袁小建,程思旸,等.单中心不同手术方式治疗全结肠型巨结肠疗效分析[J].临床小儿外科杂志,2018,17(02):106.
 Zang Jingyu,Yuan Xiaojian,Cheng Siyang,et al.The efficacy analysis of different operative methods in treating Total Colonic Aganglionosis (TCA) in a Single Center.[J].Journal of Clinical Pediatric Surgery,2018,17(05):106.
[5]吴书清,钟斌,刘辉,等. Bishop-Koop 造瘘术和双口造瘘术在新生儿坏死性小肠结肠炎中的疗效比较[J].临床小儿外科杂志,2018,17(11):835.
 Wu Shuqing,Zhong Bin,Liu Hui,et al. Comparison of therapeutic efficacies of BishopKoop stoma versus double mouth enterostomy for neonatal necrotizing enterocolitis.[J].Journal of Clinical Pediatric Surgery,2018,17(05):835.
[6]施诚仁.再谈先天性巨结肠小肠结肠炎的防治[J].临床小儿外科杂志,2019,18(05):348.[doi:10.3969/j.issn.1671-6353.2019.05.002]
 Shi Chengren.Re-discussion on prevention and treatment of congenital megacolon enterocolitis[J].Journal of Clinical Pediatric Surgery,2019,18(05):348.[doi:10.3969/j.issn.1671-6353.2019.05.002]
[7]吕志宝,盛庆丰.新生儿坏死性小肠炎的病因与诊治研究进展[J].临床小儿外科杂志,2019,18(05):352.[doi:10.3969/j.issn.1671-6353.2019.05.003]
 Lv Zhibao,Sheng Qingfeng.Advances in the etiology, diagnosis and treatment of neonatal necrotizing enterocolitis[J].Journal of Clinical Pediatric Surgery,2019,18(05):352.[doi:10.3969/j.issn.1671-6353.2019.05.003]
[8]安宗剑,孙勇.新生儿肠道菌群与坏死性小肠结肠炎发病关系的研究进展[J].临床小儿外科杂志,2019,18(05):356.[doi:10.3969/j.issn.1671-6353.2019.05.004]
 An Zongjian,Sun Yong.Research advances of neonatal intestinal microbiome and necrotising enterocolitis[J].Journal of Clinical Pediatric Surgery,2019,18(05):356.[doi:10.3969/j.issn.1671-6353.2019.05.004]
[9]梁琼鹤,蒋维维,路长贵,等.新生儿肠道手术后并发坏死性小肠结肠炎的临床特征分析[J].临床小儿外科杂志,2019,18(05):372.[doi:10.3969/j.issn.1671-6353.2019.05.007]
 Liang Qionghe,Jiang Weiwei,Lu Changgui,et al.Clinical characteristics of Necrotizing enterocolitis after neonatal intestinal surgery[J].Journal of Clinical Pediatric Surgery,2019,18(05):372.[doi:10.3969/j.issn.1671-6353.2019.05.007]
[10]杜京斌,陈永卫,郭卫红,等.新生儿坏死性小肠结肠炎手术干预指征的回顾性研究[J].临床小儿外科杂志,2019,18(05):368.[doi:10.3969/j.issn.1671-6353.2019.05.006]
 Du Jingbin,Chen Yongwei,Guo Weihong,et al.Retrospectivestudy of indications for surgical intervention inneonatal necrotizingenterocolitis[J].Journal of Clinical Pediatric Surgery,2019,18(05):368.[doi:10.3969/j.issn.1671-6353.2019.05.006]

备注/Memo

收稿日期:2018-10-13。
基金项目:贵州省科技厅联合基金资助项目(编号:黔科合LH字[2017]7100号)
通讯作者:刘远梅,Email:yuanmei116@aiyun.com

更新日期/Last Update: 1900-01-01